VR Logo

Unrated

DSP Healthcare Fund - Direct Plan


1 Lakh

Investment Grown to
₹ 1.61 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.53 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund -2.03 -1.16 -2.58 0.52 3.69 16.58 61.25 -- -- -- --
S&P BSE Healthcare TRI -3.64 -1.54 -2.22 1.27 2.82 13.70 55.76 -- -- -- --
Equity: Sectoral-Pharma -3.94 -1.28 -2.25 -0.06 2.54 14.17 55.74 -- -- -- --
Rank within category 1 1 8 2 3 2 3 -- -- -- --
Number of funds in category 9 9 9 9 9 9 9 4 4 3 0

As on 26-Feb-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
DSP Healthcare Fund - Direct Plan  | Invest Online
Unrated
Nov-18 61.25 -- -- 0.74 1,049
Nippon India Pharma Fund - Direct Plan
Unrated
Jan-13 57.07 20.90 13.93 1.04 4,197
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan  | Invest Now
Unrated
Jul-18 64.71 -- -- 1.45 2,010
SBI Healthcare Opportunities Fund - Direct Plan  | Invest Online
Unrated
Jan-13 54.41 16.85 9.18 1.12 1,551
Mirae Asset Healthcare Fund - Direct Plan  | Invest Online
Unrated
Jul-18 61.66 -- -- 0.63 1,166

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 15.08 01-Apr-2020 - 09-Apr-2020 -12.80 11-Mar-2020 - 18-Mar-2020
Month 28.70 23-Mar-2020 - 22-Apr-2020 -21.74 20-Feb-2020 - 23-Mar-2020
Quarter 42.77 23-Mar-2020 - 22-Jun-2020 -8.78 23-Dec-2019 - 23-Mar-2020
Year 88.82 09-Oct-2019 - 08-Oct-2020 -3.97 22-Mar-2019 - 23-Mar-2020

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 15.00 24.04 0.43 1.05 -- --
Equity: Sectoral-Pharma* 18.64 21.43 0.65 1.40 0.87 4.98
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Jan-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 21
Top 10 Stocks (%) 62.73
Top 5 Stocks (%) 38.75
Top 3 Sectors (%) 97.59
Portfolio P/B Ratio 4.66
Portfolio P/E Ratio 40.59

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 35,511 37,529
Giant (%) 11.31 11.40
Large (%) 39.98 45.97
Mid (%) 38.73 33.20
Small (%) 9.99 9.42
Tiny (%) -- 0.10

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Cipla Healthcare 28.35 9.58 0.00 9.29
up Lupin Healthcare 40.32 8.03 0.00 8.03
equal Dr. Reddy's Lab Healthcare 33.82 10.41 5.33 7.35
up Sun Pharmaceutical Inds. Healthcare 59.28 14.33 0.00 7.11
equal Ipca Laboratories Healthcare 22.03 11.48 6.13 6.97
equal Procter & Gamble Health Healthcare 49.97 6.12 0.00 5.78
equal Divi's Laboratories Healthcare 47.80 8.41 3.98 5.40
equal Apollo Hospitals Healthcare 217.99 5.97 1.69 5.14
equal Max Healthcare Institute Healthcare 171.63 4.13 0.00 4.13
equal Torrent Pharmaceuticals Healthcare 33.10 4.77 2.46 3.53
equal Abiomed Inc Healthcare -- 3.25
equal Intuitive Surgical Inc. (USA) Healthcare -- 3.25
equal ICICI Lombard General Insurance Company Financial 45.79 3.77 1.17 3.03
equal JB Chemicals & Pharma Healthcare 21.72 9.22 3.01 3.01
equal Narayana Hrudayalaya Healthcare -- 3.12 0.00 2.80
equal Dr. Lal Pathlabs Healthcare 79.70 3.33 1.27 2.77
equal Abbott Laboratories Healthcare -- 2.72
equal Syngene International Healthcare 61.33 3.77 1.97 2.51
equal Alkem Laboratories Healthcare 21.19 5.53 1.54 2.50
equal Indoco Remedies Healthcare 36.64 5.43 2.27 2.38
equal Alembic Pharmaceuticals Healthcare 16.09 3.90 2.02 2.02
equal Aarti Drugs Healthcare 20.44 5.29 1.96 1.96
equal Unichem Laboratories Healthcare 134.47 4.31 1.65 1.80
equal Abbott India Healthcare 47.12 3.47 0.00 0.86

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Jan-2021

Fund Manager

— Chirag Dagli since 01-Dec-2020

Education: Mr. Dagli has done B. COM and Chartered Accountant.

Experience: Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.

— Vinit Sambre since 12-Nov-2018

Education: Mr. Sambre is a B.Com and FCA.

Experience: Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999).

Interviews:

Funds Managed:


-1.16%

Change from previous, NAV as on 26-Feb-2021

Growth: ₹ 19.5800

Dividend: ₹ 19.5800


Investment Strategy

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Investment Details

Minimum Investment (₹) 500
Minimum Addl Investment (₹) 500
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 500
Lock-in Period Not Applicable
Exit Load 1% for redemption within 364 days

Basic Details

Fund House: DSP Mutual Fund
Launch Date: 30-Nov-2018
Return Since Launch: 34.91%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 1,049 Cr (As on 31-Jan-2021)
Expense: 0.74% (As on 31-Jan-2021)
Risk Grade: --
Return Grade: --
Turnover: 18.00%

Contact Information

AMC: DSP Investment Managers Pvt. Ltd.

Address: NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai - 400069

Phone: 022-66178000

Fax: 022-56578181

Website: https://www.dspim.com/

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

VR Helpline

Time for you to tread with caution?

dateSaturday, 06-Mar-2021
time04:00 PM - 04:30 PM